Search research articles
Contact Us
Filters
Showing results (411-420 of 1,250) with videos related to
Page
of 125
Sort By:
Ophthalmic Genetics
|
August 8, 2018
The treatment of refractory angle-closure glaucoma in a patient with X-linked juvenile retinoschisis
Sancy Low, Ryian Mohamed, Michelle Ting, et al.
Clinical Kidney Journal
|
April 16, 2025
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials
Emma R Webster, Adam Perkovic, Brendon L Neuen, et al.
Pain Medicine (Malden, Mass.)
|
September 17, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users
Michael D Smith, Lynn R Webster, John Lawler, et al.
Behavioural Brain Research
|
September 24, 2016
Brief isoflurane anaesthesia affects differential gene expression, gene ontology and gene networks in rat brain
Damon A Lowes, Helen F Galley, Alessandro P S Moura, et al.
Bioscience Reports
|
May 1, 1982
Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency
H A Simmonds, D R Webster, D Perrett, et al.
Pain Medicine (Malden, Mass.)
|
June 15, 2011
System dynamics modeling as a potentially useful tool in analyzing mitigation strategies to reduce overdose deaths associated with pharmaceutical opioid treatment of chronic pain
Wayne Wakeland, Teresa Schmidt, Aaron M Gilson, et al.
Pain Medicine (Malden, Mass.)
|
May 10, 2012
Randomized, double-blind, placebo-controlled study of the abuse potential of different formulations of oral oxycodone
Lynn R Webster, Brad Bath, Robert A Medve, et al.
Clinical Neuropharmacology
|
December 1, 1991
Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuations
A J Hughes, R Webster, M Bovingdon, et al.
Journal of Chemical Information and Modeling
|
November 13, 2008
SYBYL line notation (SLN): a single notation to represent chemical structures, queries, reactions, and virtual libraries
R Webster Homer, Jon Swanson, Robert J Jilek, et al.
Quality & Safety in Health Care
|
November 1, 2006
Patterns of diffusion of evidence-based clinical programmes: a case study of the Hospital Elder Life Program
Elizabeth H Bradley, Tashonna R Webster, Mark Schlesinger, et al.
Page
of 125
Search research articles
Search
Showing results (411-420 of 1,250) with videos related to
Sort By:
Page
of 125
Ophthalmic Genetics
|
August 8, 2018
The treatment of refractory angle-closure glaucoma in a patient with X-linked juvenile retinoschisis
Sancy Low, Ryian Mohamed, Michelle Ting, et al.
Clinical Kidney Journal
|
April 16, 2025
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials
Emma R Webster, Adam Perkovic, Brendon L Neuen, et al.
Pain Medicine (Malden, Mass.)
|
September 17, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users
Michael D Smith, Lynn R Webster, John Lawler, et al.
Behavioural Brain Research
|
September 24, 2016
Brief isoflurane anaesthesia affects differential gene expression, gene ontology and gene networks in rat brain
Damon A Lowes, Helen F Galley, Alessandro P S Moura, et al.
Bioscience Reports
|
May 1, 1982
Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency
H A Simmonds, D R Webster, D Perrett, et al.
Pain Medicine (Malden, Mass.)
|
June 15, 2011
System dynamics modeling as a potentially useful tool in analyzing mitigation strategies to reduce overdose deaths associated with pharmaceutical opioid treatment of chronic pain
Wayne Wakeland, Teresa Schmidt, Aaron M Gilson, et al.
Pain Medicine (Malden, Mass.)
|
May 10, 2012
Randomized, double-blind, placebo-controlled study of the abuse potential of different formulations of oral oxycodone
Lynn R Webster, Brad Bath, Robert A Medve, et al.
Clinical Neuropharmacology
|
December 1, 1991
Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuations
A J Hughes, R Webster, M Bovingdon, et al.
Journal of Chemical Information and Modeling
|
November 13, 2008
SYBYL line notation (SLN): a single notation to represent chemical structures, queries, reactions, and virtual libraries
R Webster Homer, Jon Swanson, Robert J Jilek, et al.
Quality & Safety in Health Care
|
November 1, 2006
Patterns of diffusion of evidence-based clinical programmes: a case study of the Hospital Elder Life Program
Elizabeth H Bradley, Tashonna R Webster, Mark Schlesinger, et al.
Page
of 125